Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Haleon plc

HLN•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$11.11
$-0.16(-1.42%)
U.S. Market opens in 15h 30m

Haleon plc (HLN) Stock Overview

Explore Haleon plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap49.9B
P/E Ratio15.65
EPS (TTM)$0.46
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$11.30
3 Months$12.41
1 Year Target$10.78

HLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haleon plc (HLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.05, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.78.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.65 and a market capitalization of 49.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.77%
5-Day Change
-1.51%
1-Month Change
5.83%
3-Month Change
12.16%
6-Month Change
12.73%
Year-to-Date (YTD) Change
10.70%
1-Year Change
9.06%
3-Year Change
37.005%
5-Year Change
47.60%
All-Time (Max) Change
47.60%

Contact Information

https://www.haleon.com
44 1932 822000
Building 5, Weybridge, NaN, KT13 0NY

Company Facts

245,610 Employees
IPO DateJul 25, 2022
CountryGB
Actively Trading

Frequently Asked Questions